--- title: "NEUROONE MEDICAL TECHNOLOGIES (NMTC) stock and investor profile" url: "https://aibio.space/companies/neuroone-medical-technologies/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "NEUROONE MEDICAL TECHNOLOGIES Corp (NASDAQ: NMTC), United States. Listing facts, related biotech companies and news on aibio.space." --- NMTC NEUROONE MEDICAL TECHNOLOGIES Corp NASDAQ · United States # NEUROONE MEDICAL TECHNOLOGIES (NMTC) news NEUROONE MEDICAL TECHNOLOGIES Corp is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NMTC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest NEUROONE MEDICAL TECHNOLOGIES news We have not published a story on NEUROONE MEDICAL TECHNOLOGIES yet. When there is news, it will appear here. ## NEUROONE MEDICAL TECHNOLOGIES at a glance - **Ticker**: NMTC - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $2.0 million ### Related companies - [908 Devices](https://aibio.space/companies/908-devices/) NASDAQ: MASS - [Odyssey Health](https://aibio.space/companies/odyssey-health/) OTC: ODYY - [GLOBUS MEDICAL INC](https://aibio.space/companies/globus-medical/) NYSE: GMED - [BIOMERICA INC](https://aibio.space/companies/biomerica/) NASDAQ: BMRA - [Medline](https://aibio.space/companies/medline/) NASDAQ: MDLN - [QHSLab](https://aibio.space/companies/qhslab/) OTC: USAQ - [ILLUMINA, INC.](https://aibio.space/companies/illumina/) NASDAQ: ILMN - [FAMILY OFFICE OF AMERICA, INC.](https://aibio.space/companies/family-office-of-america/) OTC: FOFA ### Also on NASDAQ - [Acumen Pharmaceuticals](https://aibio.space/companies/acumen-pharmaceuticals/) ABOS - [Aptevo Therapeutics](https://aibio.space/companies/aptevo-therapeutics/) APVO - [ICON](https://aibio.space/companies/icon/) ICLR - [ANGIODYNAMICS INC](https://aibio.space/companies/angiodynamics/) ANGO - [Oncolytics Biotech](https://aibio.space/companies/oncolytics-biotech/) ONCY - [Aura Biosciences](https://aibio.space/companies/aura-biosciences/) AURA ## NEUROONE MEDICAL TECHNOLOGIES annual financials | Line | FY ended Sep 30, 2025 | FY ended Sep 30, 2024 | |---|---|---| | Revenue | [$9.1 million](https://www.sec.gov/Archives/edgar/data/1500198/000121390025122390/) | [$3.5 million](https://www.sec.gov/Archives/edgar/data/1500198/000121390025122390/) | | Research and development | [$5.0 million](https://www.sec.gov/Archives/edgar/data/1500198/000121390025122390/) | [$5.1 million](https://www.sec.gov/Archives/edgar/data/1500198/000121390025122390/) | | Net income (loss) | [-$3.6 million](https://www.sec.gov/Archives/edgar/data/1500198/000121390025122390/) | [-$12.3 million](https://www.sec.gov/Archives/edgar/data/1500198/000121390025122390/) | | Cash from operations | [-$2.8 million](https://www.sec.gov/Archives/edgar/data/1500198/000121390025122390/) | [-$11.0 million](https://www.sec.gov/Archives/edgar/data/1500198/000121390025122390/) | | Cash and equivalents | [$6.6 million](https://www.sec.gov/Archives/edgar/data/1500198/000121390026088724/) | [$1.5 million](https://www.sec.gov/Archives/edgar/data/1500198/000121390025122390/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $2.0 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about NEUROONE MEDICAL TECHNOLOGIES What is the ticker symbol of NEUROONE MEDICAL TECHNOLOGIES? NEUROONE MEDICAL TECHNOLOGIES Corp trades under the ticker NMTC on NASDAQ. Where is NEUROONE MEDICAL TECHNOLOGIES listed? NEUROONE MEDICAL TECHNOLOGIES Corp is listed on NASDAQ. Which country or territory is NEUROONE MEDICAL TECHNOLOGIES listed under? Our directory records NEUROONE MEDICAL TECHNOLOGIES Corp under United States. Does aibio.space cover NEUROONE MEDICAL TECHNOLOGIES? aibio.space lists NEUROONE MEDICAL TECHNOLOGIES Corp among 2,820 public biotech companies and publishes its news here as stories appear. What was NEUROONE MEDICAL TECHNOLOGIES's revenue last year? $9.1 million for the fiscal year ended Sep 30, 2025, as reported to the SEC. Is NEUROONE MEDICAL TECHNOLOGIES profitable? NEUROONE MEDICAL TECHNOLOGIES Corp reported a net loss of $3.6 million for the fiscal year ended Sep 30, 2025, and used $2.8 million of cash in operations, per its annual report to the SEC. How much does NEUROONE MEDICAL TECHNOLOGIES spend on research and development? $5.0 million in the fiscal year ended Sep 30, 2025, per its annual report. How much cash does NEUROONE MEDICAL TECHNOLOGIES have? $2.0 million in cash at Jun 30, 2026, per its 10-Q. ## Investor discussion: NEUROONE MEDICAL TECHNOLOGIES Members talk about NEUROONE MEDICAL TECHNOLOGIES (NMTC). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at NEUROONE MEDICAL TECHNOLOGIES, newest first. Each line links the filing it comes from. 1. 2026-10-05 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 2.02,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1500198/000121390026106677/ea030757701ex99-1.htm) 2. 2026-06-12 Financings Reported a financing. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1500198/000121390026068327/ea0294466-8k_neuroone.htm) 3. 2026-05-22 Legal Said earlier financial statements should no longer be relied on. SEC Form 8-K (Items 4.02,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1500198/000121390026060600/ea029192501ex99-1.htm) 4. 2026-05-04 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 8.01). [Source](https://www.sec.gov/Archives/edgar/data/1500198/000121390026051158/ea0288789-8k_neuroone.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:NMTC on TradingView](https://www.tradingview.com/symbols/NASDAQ-NMTC/). ## Listing details NEUROONE MEDICAL TECHNOLOGIES Corp is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NMTC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: NEUROONE MEDICAL TECHNOLOGIES Corp - **Ticker**: NMTC - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/neuroone-medical-technologies/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "NEUROONE MEDICAL TECHNOLOGIES (NMTC) stock and investor profile", 2026-10-31, https://aibio.space/companies/neuroone-medical-technologies/